DPP3 and acute myeloid leukemia: Based on our findings, DPP3, GLRA3, CRCP, CHRNA5, CHRNE, and CHRNB1 genes that are involved in neurotransmitter pathways were found to be downregulated in the NK cells of AML patients as well.